CHICAGO — A federal court in Illinois dismissed a nationwide class action brought by consumers against Abbott Labs, whose baby formula prices spiked during a 2022 recall of tainted formula. The court says that the formula maker was not “obligated to maintain particular levels of formula production or supply or otherwise ensure stable formula prices,” and that precedent shows drug manufacturers are not statutorily required to continue supplying their medicine.
Read the ruling here.
Read about a separate, Abbott formula-related lawsuit here.
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Search Articles
